| 2024年中报 | 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 授权生产许可费(元) | - | 33,079,245.28 | 29,499,622.64 | 70,299,623.72 | 36,504,906.53 |
| 原料(含药用级、食品级)(元) | 67,535,535.09 | 135,664,056.63 | - | 82,952,327.02 | 21,264,903.21 |
| 制剂(元) | 176,622,582.68 | 254,068,223.03 | 95,369,396.05 | 167,351,965.99 | 80,144,617.34 |
| 原料(元) | - | - | 61,011,240.98 | - | - |
| 其他(元) | 4,254,856.19 | 7,087,585.48 | 2,194,529.51 | 2,265,311.71 | 748,041.67 |
| 营业成本(元) | |||||
| 授权生产许可费(元) | - | 1,276,411.20 | 963,245.50 | 2,020,000.00 | 1,009,999.80 |
| 原料(含药用级、食品级)(元) | 42,411,394.56 | 82,486,705.75 | - | 55,533,950.04 | 12,710,214.03 |
| 制剂(元) | 72,907,296.92 | 120,319,441.15 | 51,521,347.67 | 98,576,698.48 | 42,885,629.92 |
| 原料(元) | - | - | 37,589,226.41 | - | - |
| 其他(元) | 2,219,620.35 | 3,990,982.08 | 858,899.55 | 1,930,582.25 | 345,641.68 |
| 毛利(元) | |||||
| 授权生产许可费(元) | - | 31,802,834.08 | 28,536,377.14 | 68,279,623.72 | 35,494,906.73 |
| 原料(含药用级、食品级)(元) | 25,124,140.53 | 53,177,350.88 | - | 27,418,376.98 | 8,554,689.18 |
| 制剂(元) | 103,715,285.76 | 133,748,781.88 | 43,848,048.38 | 68,775,267.51 | 37,258,987.42 |
| 原料(元) | - | - | 23,422,014.57 | - | - |
| 其他(元) | 2,035,235.84 | 3,096,603.40 | 1,335,629.96 | 334,729.46 | 402,399.99 |
| 毛利率(%) | |||||
| 授权生产许可费(%) | - | 96.14 | 96.73 | 97.13 | 97.23 |
| 原料(含药用级、食品级)(%) | 37.20 | 39.20 | - | 33.05 | 40.23 |
| 制剂(%) | 58.72 | 52.64 | 45.98 | 41.10 | 46.49 |
| 原料(%) | - | - | 38.39 | - | - |
| 其他(%) | 47.83 | 43.69 | 60.86 | 14.78 | 53.79 |
| 收入构成(%) | |||||
| 授权生产许可费(%) | - | 7.69 | 15.69 | 21.77 | 26.33 |
| 原料(含药用级、食品级)(%) | 27.19 | 31.56 | - | 25.69 | 15.34 |
| 制剂(%) | 71.10 | 59.10 | 50.71 | 51.83 | 57.80 |
| 原料(%) | - | - | 32.44 | - | - |
| 其他(%) | 1.71 | 1.65 | 1.17 | 0.70 | 0.54 |
| 毛利构成(%) | |||||
| 授权生产许可费(%) | - | 14.34 | 29.38 | 41.43 | 43.44 |
| 原料(含药用级、食品级)(%) | 19.20 | 23.97 | - | 16.64 | 10.47 |
| 制剂(%) | 79.25 | 60.29 | 45.14 | 41.73 | 45.60 |
| 原料(%) | - | - | 24.11 | - | - |
| 其他(%) | 1.56 | 1.40 | 1.37 | 0.20 | 0.49 |